Evidence map›Paper›PMID 34200503›Full record

ArticleInternational journal of molecular sciences2021

Inhibition of Tunneling Nanotubes between Cancer Cell and the Endothelium Alters the Metastatic Phenotype.

Chinmayee Dash, Tanmoy Saha, Shiladitya Sengupta, Hae Lin Jang

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Future Trends in Biomaterials and Devices for Cells and Tissues.International journal of molecular sciences · 2023
    Article
  10. Review
  11. Review
  12. Tunneling Nanotubes: A New Target for Nanomedicine?International journal of molecular sciences · 2022
    Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Chinmayee DashCenter for Engineered Therapeutics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02139, USA.ORCID 0000-0002-2677-603X
Tanmoy SahaCenter for Engineered Therapeutics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02139, USA.
Shiladitya SenguptaCenter for Engineered Therapeutics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02139, USA.
Hae Lin JangCenter for Engineered Therapeutics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02139, USA.
Brigham and Women's Hospital · US

Funding

Whitlockite nanoparticle-based immunotherapy for bone metastasisR01CA236702 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI JANG, HAE LIN, SENGUPTA, SHILADITYA · 2019 to 2023
$2.7M
3D printed muscle-bone organ implant for treating large injuriesR01AR073135 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DOKMECI, MEHMET REMZI, JANG, HAE LIN · 2018 to 2022
$2.2M
American Lung Association Cancer Discovery Award LCD-618834NCI NIH HHS R01 CA236702NIAMS NIH HHS R01 AR073135NIH HHS AR073135NIH HHS CA214411NIH HHS CA229772NIH HHS CA236702U.S. Department of Defense PC180355
6 · The paper itself

Abstract

The interaction of tumor cells with blood vessels is one of the key steps during cancer metastasis. Metastatic cancer cells exhibit phenotypic state changes during this interaction: (1) they form tunneling nanotubes (TNTs) with endothelial cells, which act as a conduit for intercellular communication; and (2) metastatic cancer cells change in order to acquire an elongated phenotype, instead of the classical cellular aggregates or mammosphere-like structures, which it forms in three-dimensional cultures. Here, we demonstrate mechanistically that a siRNA-based knockdown of the exocyst complex protein Sec3 inhibits TNT formation. Furthermore, a set of pharmacological inhibitors for Rho GTPase-exocyst complex-mediated cytoskeletal remodeling is introduced, which inhibits TNT formation, and induces the reversal of the more invasive phenotype of cancer cell (spindle-like) into a less invasive phenotype (cellular aggregates or mammosphere). Our results offer mechanistic insights into this nanoscale communication and shift of phenotypic state during cancer-endothelial interactions.

Indexed as

Cell CommunicationBreast NeoplasmsCell Culture TechniquesCytoplasmCytoskeletonEndothelium, VascularFemaleHumansNanotubesNeoplasm MetastasisPhenotyperho GTP-Binding ProteinsTumor Cells, CulturedVesicular Transport Proteinsrho GTP-Binding ProteinsVesicular Transport Proteins3D cultureactin remodelingcellular aggregatesexocyst complexmammospheremetastasisphenotypic plasticityRhoGTPase inhibitortunneling nanotube (TNT)

Identifiers

PMID34200503
PMCPMC8200952
OpenAlexW3166506033

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.